 |
 |
|
NSCLC Expert Panel - Analyst Day
March 25, 2011
|
 Click here to see webcast
Hsp90 and Ganetespib Overview  |
| Safi R. Bahcall, Ph.D., President and CEO, Synta |
| |
| Evolution of NSCLC Standard of Care |
| Corey J. Langer, M.D., Hospital of the University of Pennsylvania
|
| |
| Personalized Medicine in NSCLC |
| Vincent A. Miller, M.D., Memorial Sloan-Kettering Cancer Center
|
| |
| Ganetespib in NSCLC |
| Vojo Vukovic, M.D., Ph.D., Chief Medical Officer, Synta |
| |
| Ganetespib and Docetaxel Combination in NSCLC |
| Suresh Ramalingam, M.D., Emory University School of Medicine |
| |
|
|
